Bifidobacterium animalis subsp. lactis Bi-07 supports lactose digestion in vitro and in randomized, placebo- and lactase-controlled clinical trials
- 2022-12
- RCT
- The American Journal of Clinical Nutrition 116(6)
- Pia Rasinkangas
- S. Forssten
- M. Marttinen
- A. Ibarra
- G. Bothe
- J. Junnila
- R. Uebelhack
- Y. Donazzolo
- A. Ouwehand
- PubMed: 36149331
- DOI: 10.1093/ajcn/nqac264
- High evidence
Bi-07 was superior to placebo in reducing BHC [iAUC, parts per million (ppm) ∙ h] in both trials (Booster Alpha: geometric least square mean ratio: 0.462; 95% CI: 0.249, 0.859; P = 0.016; Booster Omega: 0.227; 95% CI: 0.095, 0.543; P = 0.001).
- Effect
- Beneficial
- Effect size
- Moderate
- Significant
- Yes